Literature DB >> 1632921

The outcome from acute subdural and epidural intracranial haematomas in very elderly patients.

B Cagetti1, M Cossu, A Pau, C Rivano, G Viale.   

Abstract

Out of a consecutive series of 1082 operations performed on head-injured patients over a 9-year period, 28 cases of acute subdural haematomas (SDHs) or epidural haematomas (EDHs) occurring in patients aged between 80 and 100 years were selected. Mortality rates in these patients (100% in 2 EDHs, 88% in 26 SDHs) were significantly higher (p less than 0.01) compared with patients under 80 years (12% in 308 EDHs, 57% in 215 SDHs). Pre-existing diseases, primary events precipitating falls, and multiple system failure complicating the postoperative course accounted for most of the deaths. None of the patients operated upon with a Glasgow Coma Scale score of 11 or less survived. A typical 'talk and die' course occurred in two cases. Three patients, all operated on for SDH, survived and returned to their pre-injury conditions. It was concluded that, whilst the question as to whether to submit very old comatose patients to life-prolonging measures remains unsettled, there is a case for the prompt evacuation of extra-axial clots in patients with minimal impairment of consciousness.

Entities:  

Mesh:

Year:  1992        PMID: 1632921     DOI: 10.3109/02688699209002930

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  15 in total

Review 1.  The Neurocritical and Neurosurgical Care of Subdural Hematomas.

Authors:  Kevin T Huang; Wenya Linda Bi; Muhammad Abd-El-Barr; Sandra C Yan; Ian J Tafel; Ian F Dunn; William B Gormley
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

2.  The immense heterogeneity of frailty in neurosurgery: a systematic literature review.

Authors:  Julia Pazniokas; Chirag Gandhi; Brianna Theriault; Meic Schmidt; Chad Cole; Fawaz Al-Mufti; Justin Santarelli; Christian A Bowers
Journal:  Neurosurg Rev       Date:  2020-01-17       Impact factor: 3.042

3.  Treatment of acute subdural hematoma.

Authors:  Carter Gerard; Katharina M Busl
Journal:  Curr Treat Options Neurol       Date:  2014-01       Impact factor: 3.598

Review 4.  Surgical management of traumatic acute subdural hematoma in adults: a review.

Authors:  Hiroshi Karibe; Toshiaki Hayashi; Takayuki Hirano; Motonobu Kameyama; Atsuhiro Nakagawa; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-10-31       Impact factor: 1.742

5.  Neurological and functional outcomes of subdural hematoma evacuation in patients over 70 years of age.

Authors:  Patrick Mulligan; Bethwel Raore; Shuling Liu; Jeffrey J Olson
Journal:  J Neurosci Rural Pract       Date:  2013-07

6.  Surgical decision making for the elderly patients in severe head injuries.

Authors:  Kyeong-Seok Lee; Jae-Jun Shim; Seok-Man Yoon; Jae-Sang Oh; Hack-Gun Bae; Jae-Won Doh
Journal:  J Korean Neurosurg Soc       Date:  2014-04-30

7.  Burr Hole Drainage with Urokinase Irrigation for the Treatment of Acute Subdural Hematoma: A Case Report.

Authors:  Seong-Woo Cho; Seung-Won Choi; Jeongwook Lim; Hyon-Jo Kwon; Seon-Hwan Kim; Hyeon-Song Koh; Jin-Young Youm; Shi-Hun Song
Journal:  Korean J Neurotrauma       Date:  2018-10-31

8.  Continuous Vital Sign Analysis to Predict Secondary Neurological Decline After Traumatic Brain Injury.

Authors:  Christopher Melinosky; Shiming Yang; Peter Hu; HsiaoChi Li; Catriona H T Miller; Imad Khan; Colin Mackenzie; Wan-Tsu Chang; Gunjan Parikh; Deborah Stein; Neeraj Badjatia
Journal:  Front Neurol       Date:  2018-09-25       Impact factor: 4.003

9.  Regional Variation in the Management of Nontraumatic Subdural Hematomas Across the United States.

Authors:  David Robinson; Jane C Khoury; Dawn Kleindorfer
Journal:  World Neurosurg       Date:  2019-12-17       Impact factor: 2.104

Review 10.  Imaging in Chronic Traumatic Encephalopathy and Traumatic Brain Injury.

Authors:  Teena Shetty; Avtar Raince; Erin Manning; Apostolos John Tsiouris
Journal:  Sports Health       Date:  2015-06-05       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.